Stifel analyst Rick Wise downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and raises the price target from $23 to $27.5.
Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.